{"id":"W2073681230","doi":"10.1016/s1470-2045(11)70146-2","title":"Combination therapy in metastatic renal cell carcinoma","year":2011,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Temsirolimus; Medicine; Bevacizumab; Sunitinib; Renal cell carcinoma; Oncology; Internal medicine; Toxicity; Combination therapy; Discovery and development of mTOR inhibitors; Chemotherapy; PI3K/AKT/mTOR pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001649955,0.0005803182,0.001267736,0.0005698259,0.002252261,0.00222559,0.0009230302,0.0294996,0.005617455],"category_scores_gemma":[0.0083054,0.0004729741,0.001142611,0.0006312648,0.00140649,0.002013639,0.001303514,0.02128038,0.002957453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004236324,"about_ca_system_score_gemma":0.00201213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003547375,"about_ca_topic_score_gemma":0.01526016,"domain_scores_codex":[0.9985251,0.0005021141,0.0001442792,0.0001267407,0.0004967839,0.000205046],"domain_scores_gemma":[0.9974161,0.001565296,0.0002483441,0.00006297563,0.0002821952,0.000424986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002159721,0.00005587115,0.001101408,0.0001279217,0.00004050998,0.00378827,0.00008346121,0.0003989366,0.0003639107,0.004100722,0.9540883,0.03563463],"study_design_scores_gemma":[0.0004343307,0.0002721593,0.001913468,0.0004263369,0.00008538966,0.005688541,0.0001616564,0.001312282,0.0004178403,0.009049497,0.9801913,0.00004718225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.001210322,0.00697294,0.000143928,0.9660035,0.01605436,0.00001740828,0.00006927589,0.0000204251,0.009507869],"genre_scores_gemma":[0.01951318,0.008382812,0.0004393813,0.8806138,0.06634548,0.00008092888,0.00009905945,0.00002887766,0.02449653],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.0294996,"threshold_uncertainty_score":0.03073686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.102227183229882,"score_gpt":0.3187340458167887,"score_spread":0.2165068625869067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}